Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Achieving tobacco cessation: current status, current problems, future possibilities.

Laszlo T Vaszar1, Priscilla S A Sarinas, Glen A Lillington

  • 1Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Palo Alto, Calif., USA.

Respiration; International Review of Thoracic Diseases
|September 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative performance of shape-sensing robotic-assisted bronchoscopy and CT-guided transthoracic biopsy in diagnosing peripheral pulmonary lesions.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Diagnostic performance of monarch robotic bronchoscopy with and without mobile cone-beam CT support.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Pathological features of connective tissue disease-associated interstitial lung disease in transbronchial cryobiopsies.

Histopathology·2024
Same author

Pragmatic Clinical Trials: The Ethics of Conducting Research in the Real World.

Mayo Clinic proceedings·2024
Same author

The Thoracic Research Evaluation and Treatment 2.0 Model: A Lung Cancer Prediction Model for Indeterminate Nodules Referred for Specialist Evaluation.

Chest·2023
Same author

Emotional Distress, Anxiety, and General Health Status in Patients With Newly Identified Small Pulmonary Nodules: Results From the Watch the Spot Trial.

Chest·2023

Pharmacological aids like bupropion and nicotine therapy (NT) help reduce nicotine withdrawal symptoms for tobacco cessation. Combining these treatments increases effectiveness, though long-term abstinence rates require further research.

Area of Science:

  • Pharmacology
  • Addiction Medicine
  • Genetics

Background:

  • Tobacco cessation remains a significant challenge in public health.
  • Pharmacological interventions, including bupropion and nicotine therapy (NT), aid in achieving abstinence.
  • Current understanding of optimal clinical application for these therapies is incomplete.

Purpose of the Study:

  • To review the effectiveness of bupropion and NT in tobacco cessation.
  • To identify areas for improvement in current pharmacological cessation strategies.
  • To explore the role of genetics in nicotine dependence.

Main Methods:

  • Review of existing literature on bupropion and NT for smoking cessation.
  • Analysis of combination therapy versus monotherapy.

Related Experiment Videos

  • Examination of factors influencing abstinence rates and relapse.

    • Main Results:

    • Both bupropion and NT reduce nicotine withdrawal symptoms.
    • Combination therapy demonstrates greater effectiveness than monotherapy.
    • Higher doses of NT, with or without bupropion, increase effectiveness.
    • Initial quit rates are often below 50%, with a decline in abstinence post-therapy.

    Conclusions:

    • Pharmacological aids are beneficial but require further research for optimal use.
    • Investigating optimal dosing, duration, tapering, relapse prevention, and delivery methods for NT is crucial.
    • The genetic component of nicotine dependence warrants continued investigation.